Tumor lysis syndrome screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
Screening for tumor lysis syndrome is not recommended. However, patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup. | Screening for tumor lysis syndrome is not recommended. However, patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup. | ||
==Screening== | ==Screening== | ||
*Screening for tumor lysis syndrome is not recommended. | *Screening for tumor lysis syndrome is not recommended. | ||
*Patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup. | *Patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 12:57, 29 September 2015
|
Tumor lysis syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tumor lysis syndrome screening On the Web |
|
American Roentgen Ray Society Images of Tumor lysis syndrome screening |
|
Risk calculators and risk factors for Tumor lysis syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Screening for tumor lysis syndrome is not recommended. However, patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup.
Screening
- Screening for tumor lysis syndrome is not recommended.
- Patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup.